Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells

Fig. 6

ERRĪ± and ERG can act to co-activate the eNOS-NO signaling in prostate cancer cells. a RT-qPCR analysis of ERRĪ± and eNOS expression in prostate 3D culture spheroids versus adherent 2D culture cells. Left: spheroids (Sp) grown from DU145 or LNCaP cells exhibited higher ERRĪ± expression levels as compared to their corresponding 2D cultures. Right: spheroids exhibited significant higher eNOS expression as compared to their parental cells. Overexpression of ERRĪ± in 2D-cutured cells could significantly upregulate eNOS expression (blue bars). b Immunoblot analysis of eNOS, ERG and ERRĪ± in DU145 and LNCaP cells. The blots were cropped around the bands at 133, 55, 50 and 42Ā kDa molecular weight markers from different membrane blots. Results showed that transient overexpression of either ERG or ERRĪ± could significantly enhance protein expression of eNOS. c Measurement of cGMP levels in 3D culture spheroids derived from DU145-ERG-transduced cells. Analysis showed that DU145-ERG spheroids contained higher cGMP concentration levels than DU145-vector spheroids, and with such increased cGMP levels being eliminated by L-NIO treatment. d Immunoblot analysis of eNOS, ERG and ERRĪ± in VCaP cells upon treatments with ERRĪ± inverse agonist XCT790 (5Ā Ī¼M), ERG inhibitory peptide EIP1 (50Ā Ī¼M) or its negative control muEIP1 (50Ā Ī¼M). The blots were cropped around the bands at 133, 55, 50 and 42Ā kDa molecular weight markers from different membrane blots. Results showed that inhibition of ERRĪ± by XCT790 and also ERG by EIP1 could moderately reduce the eNOS levels in VCaP cells. e 3D culture spheroid formation assay performed on ERRĪ±-overexpressed prostate cancer cells. Results showed that overexpression of ERRĪ± could significantly promote the spheroid formation capacities of both DU145 and LNCaP cells. However, their spheroid formation capacities could be weakened by treatments with inhibitors of NOS (L-NIO, 100Ā Ī¼M) or sGC (ODQ, 20Ā Ī¼M). Results repeated at least three times are expressed as meanā€‰Ā±ā€‰SD, *Pā€‰<ā€‰0.05, **Pā€‰<ā€‰0.01. f Schematic diagram illustrates the contribution of regulatory loop between ERRĪ± and ERG in the activation of eNOS-NO-sGC-cGMP-PKG signaling pathway in the regulation of PCSCs and CRPC

Back to article page